<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Virol.</journal-id>
<journal-title>Frontiers in Virology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Virol.</abbrev-journal-title>
<issn pub-type="epub">2673-818X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fviro.2021.785678</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Virology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Systematic Identification of Endogenous Retroviral Protein-Coding Genes Expressed in Canine Oral Malignant Melanoma</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Kitao</surname> <given-names>Koichi</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/1497865/overview"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Sumiyoshi</surname> <given-names>Aoi</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Nakagawa</surname> <given-names>So</given-names></name>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/335205/overview"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Matsumoto</surname> <given-names>Yuki</given-names></name>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/1539729/overview"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Mizuno</surname> <given-names>Takuya</given-names></name>
<xref ref-type="aff" rid="aff4"><sup>4</sup></xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Miyazawa</surname> <given-names>Takayuki</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="corresp" rid="c001"><sup>&#x0002A;</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/1498188/overview"/>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>Laboratory of Virus-Host Coevolution, Institute for Frontier Life and Medical Sciences, Kyoto University</institution>, <addr-line>Kyoto</addr-line>, <country>Japan</country></aff>
<aff id="aff2"><sup>2</sup><institution>Department of Molecular Life Science, Tokai University School of Medicine</institution>, <addr-line>Isehara</addr-line>, <country>Japan</country></aff>
<aff id="aff3"><sup>3</sup><institution>Research and Development Section, Anicom Specialty Medical Institute Inc.</institution>, <addr-line>Kanagawa</addr-line>, <country>Japan</country></aff>
<aff id="aff4"><sup>4</sup><institution>Labratory of Molecular Diagnostics and Therapeutics, The United Graduate School of Veterinary Medicine, Yamaguchi University</institution>, <addr-line>Yamaguchi</addr-line>, <country>Japan</country></aff>
<author-notes>
<fn fn-type="edited-by"><p>Edited by: Jie Cui, Institut Pasteur of Shanghai (CAS), China</p></fn>
<fn fn-type="edited-by"><p>Reviewed by: Jumpei Ito, University of Tokyo, Japan; Hee-Jae Cha, Kosin University, South Korea</p></fn>
<corresp id="c001">&#x0002A;Correspondence: Takayuki Miyazawa <email>takavet&#x00040;infront.kyoto-u.ac.jp</email></corresp>
<fn fn-type="other" id="fn001"><p>This article was submitted to Viral Diversification and Evolution, a section of the journal Frontiers in Virology</p></fn></author-notes>
<pub-date pub-type="epub">
<day>24</day>
<month>11</month>
<year>2021</year>
</pub-date>
<pub-date pub-type="collection">
<year>2021</year>
</pub-date>
<volume>1</volume>
<elocation-id>785678</elocation-id>
<history>
<date date-type="received">
<day>29</day>
<month>09</month>
<year>2021</year>
</date>
<date date-type="accepted">
<day>03</day>
<month>11</month>
<year>2021</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#x000A9; 2021 Kitao, Sumiyoshi, Nakagawa, Matsumoto, Mizuno and Miyazawa.</copyright-statement>
<copyright-year>2021</copyright-year>
<copyright-holder>Kitao, Sumiyoshi, Nakagawa, Matsumoto, Mizuno and Miyazawa</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/"><p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p></license> 
</permissions>
<abstract><p>Endogenous retroviruses (ERVs) are remnants of ancestral retroviruses that infected host germ cells in the past. Most ERVs are thought to be non-functional elements, but some ERVs retain open reading frames (ORFs) capable of expressing proteins. The proteins encoded by ERV-ORFs have potential roles in oncogenesis; however, studies on mammals other than humans and mice are limited. Here, we identified ERV-derived genes expressed in canine oral malignant melanoma (OMM). We identified 11 ERV-derived genes in our OMM samples. Differential expression gene analysis revealed that four ERV-derived genes (<italic>PEG10, LOC102155597</italic>, and two newly identified genes) were upregulated in OMM compared to healthy tissues. <italic>PEG10</italic> is a conserved long terminal repeat (LTR)-type retrotransposon-derived gene among mammals and is involved in human cancers. <italic>LOC102155597</italic> is a retroviral <italic>env</italic> gene conserved in Carnivora. This Env protein harbors an immunosuppressive domain, implying the potential adverse effects on the immune system. While the production of viral particles from ERVs has been reported in human and mouse melanoma, we found no ERV-derived genes having the potential to produce viral particles. These results provide insights into the different and conserved features of ERV-derived genes in mammalian melanoma.</p></abstract>
<kwd-group>
<kwd>dog</kwd>
<kwd>endogenous retrovirus</kwd>
<kwd>oral malignant melanoma</kwd>
<kwd>protein-coding gene</kwd>
<kwd>RNA-Seq</kwd>
</kwd-group>
<contract-sponsor id="cn001">Japan Society for the Promotion of Science<named-content content-type="fundref-id">10.13039/501100001691</named-content></contract-sponsor>
<counts>
<fig-count count="4"/>
<table-count count="2"/>
<equation-count count="0"/>
<ref-count count="43"/>
<page-count count="11"/>
<word-count count="5625"/>
</counts>
</article-meta>
</front>
<body>
<sec sec-type="intro" id="s1">
<title>Introduction</title>
<p>Endogenous retroviruses (ERVs) are remnants of ancient retroviral infections to germ cells and have accumulated in all mammalian genomes (<xref ref-type="bibr" rid="B1">1</xref>). Retroviruses have three structural and enzymatic genes: <italic>gag</italic> gene encoding the major structural protein; <italic>pol</italic> gene encoding a polyprotein consisting of multiple proteins including protease, reverse transcriptase, RNase H, and integrase; <italic>env</italic> gene encoding the envelope protein. In addition, some retroviruses encode regulatory and/or accessory genes that control viral gene expression and/or suppress host defense mechanisms. Most ERVs have lost their open reading frames (ORFs) due to the accumulation of mutations. However, some genes derived from ERVs are expressed as proteins in host cells when the ORFs are still intact because they are young ERVs, or when the ORFs are domesticated as <italic>de novo</italic> host genes (<xref ref-type="bibr" rid="B1">1</xref>).</p>
<p>In human melanoma, aberrant expression of ERVs has been reported to be associated with oncogenesis (<xref ref-type="bibr" rid="B2">2</xref>). Human ERV-K (HERV-K) is actively expressed in human melanoma, and their protein expression, as well as particle formation, have been reported (<xref ref-type="bibr" rid="B3">3</xref>, <xref ref-type="bibr" rid="B4">4</xref>). ERV3-1, an <italic>env</italic> gene of HERV-R, is also reported to be expressed in colorectal cancers (<xref ref-type="bibr" rid="B5">5</xref>) and acute myelogenous leukemia (<xref ref-type="bibr" rid="B6">6</xref>). In mice, active expression of an ERV called MelARV has been reported in B16/BL6 melanoma cells (<xref ref-type="bibr" rid="B7">7</xref>, <xref ref-type="bibr" rid="B8">8</xref>). Knockdown of MelARV reduces the aggressiveness of B16 melanoma in transplanted mice (<xref ref-type="bibr" rid="B9">9</xref>). They proposed a functional model in which Env protein of MelARV regulates regulatory T cells (<xref ref-type="bibr" rid="B9">9</xref>). Thus, aberrantly expressed ERV genes may be a promising therapeutic target for melanoma. However, the association between melanoma and ERVs in mammals other than humans and mice remains unresolved.</p>
<p>Long terminal repeat (LTR)-type retrotransposons that mainly correspond to ERVs comprise 8 and 10% of the human and mouse genomes, respectively (<xref ref-type="bibr" rid="B10">10</xref>, <xref ref-type="bibr" rid="B11">11</xref>). The overall proportion of ERVs as well as their lineages varies greatly among mammalian species (<xref ref-type="bibr" rid="B12">12</xref>). In the dog genome, for example, a proportion of genomic regions corresponding to ERVs is relatively low at 4.85% (<xref ref-type="bibr" rid="B13">13</xref>). According to a comprehensive study identifying ERV-derived ORFs (ERV-ORFs) in the genome, the number of canine ERV-ORFs is one-third of those in humans (<xref ref-type="bibr" rid="B14">14</xref>). Therefore, the expressed ERV-derived genes in canine melanoma are supposed to be fewer than in human and mouse melanoma; however, comprehensive characterization of ERVs expressed in canine melanoma has not been performed.</p>
<p>Canine oral malignant melanoma (OMM) is a highly metastatic tumor in dogs, spreading to the lung, lymph nodes, and liver, and shows a grave prognosis (<xref ref-type="bibr" rid="B15">15</xref>). Surgical resection and radiation are first-line treatments for OMM cases with no metastasis; however, there are no effective systemic treatments after metastasis (<xref ref-type="bibr" rid="B15">15</xref>). Canine cancers, including OMM, have been proposed as research models for human cancer studies (<xref ref-type="bibr" rid="B16">16</xref>, <xref ref-type="bibr" rid="B17">17</xref>). On the contrary, the applications of the cancer therapies developed in humans to dogs are also underway, such as the administration of immune checkpoint inhibitors (<xref ref-type="bibr" rid="B18">18</xref>, <xref ref-type="bibr" rid="B19">19</xref>). These studies have shown the effectiveness of strategies targeting genes conserved in humans and dogs. Though most ERVs are not conserved in humans and dogs, considering the active expression of ERVs in human and mouse melanoma, it is plausible that ERVs, including canine-specific ones, are expressed in canine OMM. Since cancer-specific ERVs may not be detectable in normal tissues, <italic>de novo</italic> transcripts in OMM samples, in addition to the reference transcripts, are required for the comprehensive gene expression analysis. Here, we made a catalog of transcripts retaining the ERV-ORFs that are expressed in canine OMM samples and conducted differential gene expression analyses. Since ERVs are involved in oncogenesis in humans and mice, these canine ERVs have the potential to be new therapeutic targets and markers. This study also will provide a model for studying ERVs&#x00027; common roles in melanoma across mammalian species.</p>
</sec>
<sec sec-type="materials and methods" id="s2">
<title>Materials and Methods</title>
<sec>
<title>RNA Sequencing</title>
<p>Canine OMM samples (<italic>n</italic> = 8) were obtained following surgical resection as treatment at Animal Medical Center, Yamaguchi University (<xref ref-type="table" rid="T1">Table 1</xref>). The bleed of all dogs used in this study was Dachshund. The patient&#x00027;s owners were informed before sample collection. Total RNA was isolated from fresh OMM from eight dogs using RNA Premium Kit (FastGene &#x00023;FG-81050). We collected mRNA by NEBNext Poly(A) mRNA Magnetic Isolation Module (NEB &#x00023;E7490). Strand-specific libraries were generated by NEBNext Ultra Directional RNA Library Prep Kit for Illumina (NEB &#x00023;E7420) and indexed by NEBNext Multiplex Oligos for Illumina (NEB &#x00023;E7335). All libraries were sequenced on Illumina NextSeq 500. We also obtained transcriptome sequencing data of canine OMM and oral healthy tissues (8 and 3 samples, respectively) from NCBI sequence read archives (<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/sra">https://www.ncbi.nlm.nih.gov/sra</ext-link>) (<xref ref-type="bibr" rid="B20">20</xref>) to confirm our RNA-seq analyses. Accession numbers and read mapping results were summarized in <xref ref-type="supplementary-material" rid="SM1">Supplementary Table 1</xref>.</p>
<table-wrap position="float" id="T1">
<label>Table 1</label>
<caption><p>Tumor location, breed, age, and gender.</p></caption>
<table frame="hsides" rules="groups">
<thead><tr>
<th valign="top" align="left"><bold>Case</bold></th>
<th valign="top" align="left"><bold>Age</bold></th>
<th valign="top" align="left"><bold>Gender</bold></th>
<th valign="top" align="center"><bold>Number of reads</bold></th>
<th valign="top" align="center"><bold>Mapping rate (%)</bold></th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">1</td>
<td valign="top" align="left">Unknown</td>
<td valign="top" align="left">Unknown</td>
<td valign="top" align="center">76,852,209</td>
<td valign="top" align="center">93.94</td>
</tr>
<tr>
<td valign="top" align="left">2</td>
<td valign="top" align="left">13Y9M</td>
<td valign="top" align="left">Castrated male</td>
<td valign="top" align="center">83,562,483</td>
<td valign="top" align="center">94.29</td>
</tr>
<tr>
<td valign="top" align="left">3</td>
<td valign="top" align="left">Unknown</td>
<td valign="top" align="left">Unknown</td>
<td valign="top" align="center">81,698,415</td>
<td valign="top" align="center">93.14</td>
</tr>
<tr>
<td valign="top" align="left">4</td>
<td valign="top" align="left">8Y3M</td>
<td valign="top" align="left">Spayed female</td>
<td valign="top" align="center">64,190,554</td>
<td valign="top" align="center">92.68</td>
</tr>
<tr>
<td valign="top" align="left">5</td>
<td valign="top" align="left">16Y</td>
<td valign="top" align="left">Castrated male</td>
<td valign="top" align="center">82,291,328</td>
<td valign="top" align="center">92.87</td>
</tr>
<tr>
<td valign="top" align="left">6</td>
<td valign="top" align="left">Unknown</td>
<td valign="top" align="left">Unknown</td>
<td valign="top" align="center">83,826,245</td>
<td valign="top" align="center">94.46</td>
</tr>
<tr>
<td valign="top" align="left">7</td>
<td valign="top" align="left">14Y</td>
<td valign="top" align="left">Spayed female</td>
<td valign="top" align="center">74,349,680</td>
<td valign="top" align="center">93.93</td>
</tr>
<tr>
<td valign="top" align="left">8</td>
<td valign="top" align="left">9Y7M</td>
<td valign="top" align="left">Castrated male</td>
<td valign="top" align="center">79,606,779</td>
<td valign="top" align="center">94.20</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<p><italic>Reads/Mapping rate</italic>.</p>
</table-wrap-foot>
</table-wrap>
</sec>
<sec>
<title>Transcript Assembly</title>
<p>All paired-end FASTQ files were trimmed, and their sequence qualities were checked using Trim Galore (version 0.6.4) (<ext-link ext-link-type="uri" xlink:href="https://www.bioinformatics.babraham.ac.uk/projects/trim_galore/">https://www.bioinformatics.babraham.ac.uk/projects/trim_galore/</ext-link>). Then, the filtered short reads were aligned to the canine reference genome (un-masked canFam3 genome from UCSC genome browser: <ext-link ext-link-type="uri" xlink:href="https://hgdownload.soe.ucsc.edu/goldenPath/canFam3/bigZips/">https://hgdownload.soe.ucsc.edu/goldenPath/canFam3/bigZips/</ext-link>) using HISAT2 (version 2.1.0) (<xref ref-type="bibr" rid="B21">21</xref>). For each RNA-seq sample, we conducted transcript assemblies using StringTie2 (version 2.1.1) (<xref ref-type="bibr" rid="B21">21</xref>) with &#x0201C;&#x02013;rf&#x0201D; options to specify strandedness. Resultant GTF files obtained from the eight canine OMM samples and the canine RefSeq GTF file (canFam3, downloaded from UCSC genome browser on June 15, 2021) were merged using StringTie2 with &#x0201C;&#x02013;merge&#x0201D; option to generate a merged GTF file. The &#x0201C;-m 500 -f 0.05&#x0201D; options were combined to improve the specificity of the transcript assembly. Each melanoma transcript identical to a RefSeq transcript was allocated to the RefSeq nomenclature. The resultant transcript assemblies are available in <xref ref-type="supplementary-material" rid="SM5">Supplementary File 1</xref> (a compressed GTF file).</p>
</sec>
<sec>
<title>Detection of ERV-Derived Genes</title>
<p>A BED file of canine ERV-ORFs was downloaded from gEVE (version 1.1) (<ext-link ext-link-type="uri" xlink:href="http://geve.med.u-tokai.ac.jp/">http://geve.med.u-tokai.ac.jp/</ext-link>) (<xref ref-type="bibr" rid="B14">14</xref>). In gEVE, <italic>pol</italic> genes that were thought to be derived from long interspersed nuclear elements (LINEs) were included (<xref ref-type="bibr" rid="B14">14</xref>). To remove LINE-derived sequences, ERV-ORFs which were annotated as &#x0201C;LINE&#x0201D; by RepeatMasker and/or &#x0201C;YP_073558.1&#x0201D; or &#x0201C;NP_048132.1&#x0201D; by BLASTP against the NCBI Viral Genome Database were removed. Transcripts in the merged GTF file overlapped with ERV-ORFs were identified using BEDtools intersect with &#x0201C;-s&#x0201D; option to consider strandedness (<xref ref-type="bibr" rid="B22">22</xref>). Forty-three ERV-derived genes detected at this step were listed in <xref ref-type="supplementary-material" rid="SM2">Supplementary Table 2</xref>. All ERV-derived genes were manually checked using Integrative Genomics Viewer (version 2.4.9) (<xref ref-type="bibr" rid="B23">23</xref>). Transcripts per kilobase million (TPM) was calculated using StringTie2 with &#x0201C;-e &#x02013;rf&#x0201D; options using the merged GTF file. Eleven ERV-derived genes with the mean TPM &#x0003E; 1 were listed including <italic>Canis-env2</italic> (<xref ref-type="table" rid="T2">Table 2</xref>). Differentially expressed genes were identified and visualized with an MA plot and a volcano plot using DESeq2 (version 1.26.0) (<xref ref-type="bibr" rid="B24">24</xref>) in R (version 3.6.1).</p>
<table-wrap position="float" id="T2">
<label>Table 2</label>
<caption><p>Curated 11 ERV-derived genes, TPMs, and overlapped ERV-ORFs.</p></caption>
<table frame="hsides" rules="groups">
<thead><tr>
<th valign="top" align="left"><bold>RefSeq name</bold></th>
<th valign="top" align="center"><bold>AverageTPM<xref ref-type="table-fn" rid="TN1"><sup>a</sup></xref></bold></th>
<th valign="top" align="left"><bold>ERV-ORF (gEVE ID)</bold></th>
<th valign="top" align="center"><bold>Amino acid length<xref ref-type="table-fn" rid="TN2"><sup>b</sup></xref> (ATG-starting)</bold></th>
<th valign="top" align="center"><bold>Overlapping ratio<xref ref-type="table-fn" rid="TN3"><sup>c</sup></xref></bold></th>
<th valign="top" align="left"><bold>HMM profile</bold></th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">NA (NMG-1)</td>
<td valign="top" align="center">1.28</td>
<td valign="top" align="left">Cfam31.chr1.17538.18311.-</td>
<td valign="top" align="center">258 (222)</td>
<td valign="top" align="center">1</td>
<td valign="top" align="left">POL</td>
</tr>
<tr>
<td/>
<td/>
<td valign="top" align="left">Cfam31.chr1.18315.18689.-</td>
<td valign="top" align="center">125 (3)</td>
<td valign="top" align="center">1</td>
<td valign="top" align="left">RNaseH</td>
</tr>
<tr>
<td/>
<td/>
<td valign="top" align="left">Cfam31.chr1.18799.19509.-</td>
<td valign="top" align="center">237 (212)</td>
<td valign="top" align="center">1</td>
<td valign="top" align="left">GAG</td>
</tr>
<tr>
<td/>
<td/>
<td valign="top" align="left">Cfam31.chr1.19475.19843.-</td>
<td valign="top" align="center">123 (109)</td>
<td valign="top" align="center">0.37</td>
<td valign="top" align="left">GAG</td>
</tr>
<tr>
<td valign="top" align="left">ASPRV1</td>
<td valign="top" align="center">2.11</td>
<td valign="top" align="left">Cfam31.chr10.68586978.68587886.-</td>
<td valign="top" align="center">303 (263)</td>
<td valign="top" align="center">1</td>
<td valign="top" align="left">AP</td>
</tr>
<tr>
<td valign="top" align="left">LOC102155597</td>
<td valign="top" align="center">9.56</td>
<td valign="top" align="left">Cfam31.chr12.71944605.71944928.-</td>
<td valign="top" align="center">108 (0)</td>
<td valign="top" align="center">0.37</td>
<td valign="top" align="left">POL</td>
</tr>
<tr>
<td/>
<td/>
<td valign="top" align="left">Cfam31.chr12.71944903.71945781.-</td>
<td valign="top" align="center">293 (224)</td>
<td valign="top" align="center">1</td>
<td valign="top" align="left">POL</td>
</tr>
<tr>
<td/>
<td/>
<td valign="top" align="left">Cfam31.chr12.71945669.71946616.-</td>
<td valign="top" align="center">316 (271)</td>
<td valign="top" align="center">1</td>
<td valign="top" align="left">POL</td>
</tr>
<tr>
<td/>
<td/>
<td valign="top" align="left">Cfam31.chr12.71946828.71947217.-</td>
<td valign="top" align="center">130 (130)</td>
<td valign="top" align="center">1</td>
<td valign="top" align="left">RT</td>
</tr>
<tr>
<td/>
<td/>
<td valign="top" align="left">Cfam31.chr12.71947221.71947559.-</td>
<td valign="top" align="center">113 (70)</td>
<td valign="top" align="center">1</td>
<td valign="top" align="left">AP</td>
</tr>
<tr>
<td/>
<td/>
<td valign="top" align="left">Cfam31.chr12.71947774.71948322.-</td>
<td valign="top" align="center">183 (141)</td>
<td valign="top" align="center">1</td>
<td valign="top" align="left">PRO</td>
</tr>
<tr>
<td/>
<td/>
<td valign="top" align="left">Cfam31.chr12.71948376.71948984.-</td>
<td valign="top" align="center">203 (170)</td>
<td valign="top" align="center">1</td>
<td valign="top" align="left">GAG</td>
</tr>
<tr>
<td/>
<td/>
<td valign="top" align="left">Cfam31.chr12.71948785.71949063.-</td>
<td valign="top" align="center">93 (75)</td>
<td valign="top" align="center">1</td>
<td valign="top" align="left">GAG</td>
</tr>
<tr>
<td/>
<td/>
<td valign="top" align="left">Cfam31.chr12.71949067.71950053.-</td>
<td valign="top" align="center">329 (320)</td>
<td valign="top" align="center">1</td>
<td valign="top" align="left">GAG</td>
</tr>
<tr>
<td valign="top" align="left">LOC111098614/LOC102154912</td>
<td valign="top" align="center">14.94</td>
<td valign="top" align="left">Cfam31.chr13.45478479.45479102.&#x0002B;</td>
<td valign="top" align="center">208 (168)</td>
<td valign="top" align="center">0.21</td>
<td valign="top" align="left">INT</td>
</tr>
<tr>
<td/>
<td/>
<td valign="top" align="left">Cfam31.chr13.45479000.45479401.&#x0002B;</td>
<td valign="top" align="center">134 (27)</td>
<td valign="top" align="center">0.49</td>
<td valign="top" align="left">POL</td>
</tr>
<tr>
<td/>
<td/>
<td valign="top" align="left">Cfam31.chr13.45480576.45480908.&#x0002B;</td>
<td valign="top" align="center">111 (87)</td>
<td valign="top" align="center">0.85</td>
<td valign="top" align="left">ENV</td>
</tr>
<tr>
<td valign="top" align="left">PEG10</td>
<td valign="top" align="center">11.11</td>
<td valign="top" align="left">Cfam31.chr14.20127798.20128877.&#x0002B;</td>
<td valign="top" align="center">360 (305)</td>
<td valign="top" align="center">1</td>
<td valign="top" align="left">GAG</td>
</tr>
<tr>
<td/>
<td/>
<td valign="top" align="left">Cfam31.chr14.20128379.20129443.&#x0002B;</td>
<td valign="top" align="center">355 (163)</td>
<td valign="top" align="center">1</td>
<td valign="top" align="left">AP</td>
</tr>
<tr>
<td valign="top" align="left">NA (NMG-2)</td>
<td valign="top" align="center">2.01</td>
<td valign="top" align="left">Cfam31.chr2.10127277.10127657.-</td>
<td valign="top" align="center">127 (108)</td>
<td valign="top" align="center">0.36</td>
<td valign="top" align="left">GAG</td>
</tr>
<tr>
<td valign="top" align="left">LOC111093532</td>
<td valign="top" align="center">18.55</td>
<td valign="top" align="left">Cfam31.chr31.38015118.38015360.-</td>
<td valign="top" align="center">81 (68)</td>
<td valign="top" align="center">1</td>
<td valign="top" align="left">ENV</td>
</tr>
<tr>
<td/>
<td/>
<td valign="top" align="left">Cfam31.chr31.38015533.38016231.-</td>
<td valign="top" align="center">233 (29)</td>
<td valign="top" align="center">1</td>
<td valign="top" align="left">ENV</td>
</tr>
<tr>
<td/>
<td/>
<td valign="top" align="left">Cfam31.chr31.38016117.38016590.-</td>
<td valign="top" align="center">158 (34)</td>
<td valign="top" align="center">1</td>
<td valign="top" align="left">ENV</td>
</tr>
<tr>
<td/>
<td/>
<td valign="top" align="left">Cfam31.chr31.38016809.38017414.-</td>
<td valign="top" align="center">202 (188)</td>
<td valign="top" align="center">0.52</td>
<td valign="top" align="left">INT</td>
</tr>
<tr>
<td/>
<td/>
<td valign="top" align="left">Cfam31.chr31.38017418.38018188.-</td>
<td valign="top" align="center">257 (150)</td>
<td valign="top" align="center">0.12</td>
<td valign="top" align="left">POL</td>
</tr>
<tr>
<td valign="top" align="left">LOC111094052</td>
<td valign="top" align="center">1.65</td>
<td valign="top" align="left">Cfam31.chr35.24271063.24272484.&#x0002B;</td>
<td valign="top" align="center">474 (447)</td>
<td valign="top" align="center">1</td>
<td valign="top" align="left">ENV</td>
</tr>
<tr>
<td valign="top" align="left">LOC111094054</td>
<td valign="top" align="center">7.17</td>
<td valign="top" align="left">Cfam31.chr35.24996009.24996902.-</td>
<td valign="top" align="center">298 (194)</td>
<td valign="top" align="center">0.80</td>
<td valign="top" align="left">GAG</td>
</tr>
<tr>
<td/>
<td/>
<td valign="top" align="left">Cfam31.chr35.24996945.24997460.-</td>
<td valign="top" align="center">172 (71)</td>
<td valign="top" align="center">0.28</td>
<td valign="top" align="left">GAG</td>
</tr>
<tr>
<td/>
<td/>
<td valign="top" align="left">Cfam31.chr35.24991408.24991809.-</td>
<td valign="top" align="center">134 (31)</td>
<td valign="top" align="center">1</td>
<td valign="top" align="left">ENV</td>
</tr>
<tr>
<td/>
<td/>
<td valign="top" align="left">Cfam31.chr35.24991822.24992172.-</td>
<td valign="top" align="center">117 (107)</td>
<td valign="top" align="center">1</td>
<td valign="top" align="left">ENV</td>
</tr>
<tr>
<td/>
<td/>
<td valign="top" align="left">Cfam31.chr35.24992111.24992359.-</td>
<td valign="top" align="center">83 (21)</td>
<td valign="top" align="center">1</td>
<td valign="top" align="left">ENV</td>
</tr>
<tr>
<td/>
<td/>
<td valign="top" align="left">Cfam31.chr35.24992564.24992989.-</td>
<td valign="top" align="center">142 (0)</td>
<td valign="top" align="center">1</td>
<td valign="top" align="left">ENV</td>
</tr>
<tr>
<td/>
<td/>
<td valign="top" align="left">Cfam31.chr35.24993046.24993933.-</td>
<td valign="top" align="center">296 (187)</td>
<td valign="top" align="center">1</td>
<td valign="top" align="left">POL</td>
</tr>
<tr>
<td/>
<td/>
<td valign="top" align="left">Cfam31.chr35.24995423.24995950.-</td>
<td valign="top" align="center">176 (104)</td>
<td valign="top" align="center">0.72</td>
<td valign="top" align="left">POL</td>
</tr>
<tr>
<td valign="top" align="left">NA (NMG-3)</td>
<td valign="top" align="center">5.12</td>
<td valign="top" align="left">Cfam31.chr8.4429849.4430145.&#x0002B;</td>
<td valign="top" align="center">99 (68)</td>
<td valign="top" align="center">0.10</td>
<td valign="top" align="left">INT</td>
</tr>
<tr>
<td valign="top" align="left">NA (NMG-4)</td>
<td valign="top" align="center">3.56</td>
<td valign="top" align="left">Cfam31.chrX.107190737.107191321.&#x0002B;</td>
<td valign="top" align="center">195 (110)</td>
<td valign="top" align="center">0.30</td>
<td valign="top" align="left">GAG</td>
</tr>
<tr>
<td/>
<td/>
<td valign="top" align="left">Cfam31.chrX.107193576.107193956.&#x0002B;</td>
<td valign="top" align="center">127 (7)</td>
<td valign="top" align="center">1</td>
<td valign="top" align="left">RNaseH</td>
</tr>
<tr>
<td/>
<td/>
<td valign="top" align="left">Cfam31.chrX.107194162.107194650.&#x0002B;</td>
<td valign="top" align="center">163 (129)</td>
<td valign="top" align="center">1</td>
<td valign="top" align="left">INT</td>
</tr>
<tr>
<td/>
<td/>
<td valign="top" align="left">Cfam31.chrX.107194524.107194814.&#x0002B;</td>
<td valign="top" align="center">97 (73)</td>
<td valign="top" align="center">1</td>
<td valign="top" align="left">INT</td>
</tr>
<tr>
<td/>
<td/>
<td valign="top" align="left">Cfam31.chrX.107195119.107195367.&#x0002B;</td>
<td valign="top" align="center">83 (9)</td>
<td valign="top" align="center">1</td>
<td valign="top" align="left">ENV</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<p><italic>TPM, Transcripts per kilobase million; HMM profile, significant retroviral motif profiles obtained by hidden Markov models (HMM); NMG, newly identified melanoma gene; AP, aspartic protease; INT, integrase</italic>.</p> 
<fn id="TN1">
<label>a</label>
<p><italic>TPM values are mean values of eight canine oral malignant melanoma samples</italic>.</p></fn>
<fn id="TN2">
<label>b</label>
<p><italic>Including non-ATG starting</italic>.</p></fn>
<fn id="TN3">
<label>c</label>
<p><italic>Ratios of ERV-ORFs overlapping with transcripts</italic>.</p></fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec>
<title>RT-PCR</title>
<p>Total RNA was extracted from cultured OMM cells from four animals (<xref ref-type="supplementary-material" rid="SM3">Supplementary Table 3</xref>), which were maintained in Dulbecco&#x00027;s modified Eagle medium (Sigma-Aldrich &#x00023;D5796) supplemented with 10% heat-inactivated fetal bovine serum (Gibco &#x00023;10270), penicillin (100 IU/ml) and streptomycin (100 &#x003BC;g/ml) (Nacalai tesuque &#x00023; 09367-34). To synthesize the cDNA, RNA was reverse transcribed using Verso cDNA Synthesis kit (Thermo Fisher Scientific &#x00023;AB1453B). For negative controls, samples without reverse transcriptase were prepared. PCR was performed using KOD One (TOYOBO &#x00023;KMM-101). Primer pairs used for NMG-1 and NMG-4 were 5&#x02032;-ACCCGCTGACTATGACTCAGGAAC-3&#x02032; (forward) and 5&#x02032;-AACAGTCTTTGCCTCTGCTGTCAG-3&#x02032; (reverse), and 5&#x02032;-AGGCACTCCTCCACGCCACTACTAG-3&#x02032; (forward) and 5&#x02032;-TCAAGTCTGTGCTTATGTAGGGACCAG-3&#x02032; (reverse), respectively. For loading control, GAPDH was amplified with a primer pair, 5&#x02032;-AAGGTCGGAGTGAACGGATTTGG-3&#x02032; (forward) and 5&#x02032;-CGGTTGCTGTAGCCAAATTCATTG-3&#x02032; (reverse). After preheating at 94&#x000B0;C for 2 min, thermal cycling reaction (98&#x000B0;C for 10 s and 68&#x000B0;C for 10 s) was repeated 35 times (for NMG-1 and NMG-4) or 30 times (for GAPDH). The sequences of the amplicons were checked by the Sanger sequencing (Fasmac Co., Ltd.).</p>
</sec>
<sec>
<title>Evolutionally Analyses of <italic>Canis-Env2</italic></title>
<p>To collect <italic>Canis-env2</italic> orthologs in Carnivora genomes, coding sequences of <italic>Canis-env2</italic> in the dog was searched using Blat (<xref ref-type="bibr" rid="B25">25</xref>) in the following represented species in the UCSC genome browser (<ext-link ext-link-type="uri" xlink:href="https://genome.ucsc.edu">https://genome.ucsc.edu</ext-link>): Southern Sea otter, enhLutNer1 (Jun. 2019); Ferret, musFur1 (Apr. 2011); Hawaiian monk seal, neoSch1 (Jun. 2017); panda, ailMel1 (Dec. 2009); and Cat, felCat9 (Nov. 2017). The hits with the highest similarity scores were confirmed to be located between <italic>BTN2A1</italic> and <italic>BTN1A1</italic>. To conduct the following evolutionary analyses of <italic>Canis-env2</italic>, we used MEGA-X (<xref ref-type="bibr" rid="B26">26</xref>). We first aligned nucleotide sequences of <italic>Canis-env2</italic> genes by MUSCLE program with &#x0201C;Align codons&#x0201D; option (<xref ref-type="bibr" rid="B27">27</xref>), and pairwise <italic>p</italic>-distance values of amino acids, which are proportions of amino acid sites at which the two sequences to be compared are different, were calculated. The numbers of non-synonymous substitutions (<italic>dN</italic>) and synonymous substitutions (<italic>dS</italic>) per site were estimated by Nei-Gojobori method with Jukes-Canter correlation (<xref ref-type="bibr" rid="B28">28</xref>).</p>
</sec>
</sec>
<sec sec-type="results" id="s3">
<title>Results</title>
<sec>
<title>Identification of Transcriptionally Active ERV-Derived Genes in Canine OMM</title>
<p>We conducted RNA-seq analyses using canine oral malignant melanoma (OMM) cases (<italic>n</italic> = 8). To identify ERV-derived genes from these sequence data, we constructed a pipeline to identify ERV-ORFs expressed in canine melanoma (<xref ref-type="fig" rid="F1">Figure 1A</xref>). First, we constructed <italic>de novo</italic> transcript assemblies with reference to the RefSeq gene coordinates using StringTie2. In this procedure, transcripts expressed from the overlapped locus were given a single gene name. In total, we obtained 106,209 transcripts from the 8 OMM RNA-seq samples, and these transcripts were organized into 34,292 genes, of which 3,035 genes were not reported in the reference gene annotation (<xref ref-type="fig" rid="F1">Figure 1B</xref>). Next, we extracted genes whose transcripts were overlapped with ERV-ORFs in the gEVE database (<ext-link ext-link-type="uri" xlink:href="http://geve.med.u-tokai.ac.jp/">http://geve.med.u-tokai.ac.jp/</ext-link>) (<xref ref-type="bibr" rid="B14">14</xref>) (<xref ref-type="fig" rid="F1">Figure 1C</xref>). As a result, we obtained 43 genes, of which five genes were newly identified (<xref ref-type="fig" rid="F1">Figure 1D</xref>, <xref ref-type="supplementary-material" rid="SM2">Supplementary Table 2</xref>).</p>
<fig id="F1" position="float">
<label>Figure 1</label>
<caption><p>Identification of ERV-derived genes from canine OMM. <bold>(A)</bold> Schematic representation of the pipeline for detection of ERV-derived genes. <bold>(B)</bold> The numbers of genes and transcripts identified in the RNA-seq analysis. <bold>(C)</bold> The extraction method for ERV-derived genes. Genes of which exon(s) were overlapped with the same coordinates annotated in the gEVE database were defined as ERV-derived genes. Note that genes whose intron(s) were overlapped with the gEVE annotation, or genes overlapped with the gEVE annotation in reverse direction were not regarded to ERV-derived genes. <bold>(D)</bold> Names of ERV-derived genes. Five ERV-derived genes were not found in the RefSeq genes. Twenty ERV-derived genes were annotated in the RefSeq database and expressed in the OMM samples. Eighteen ERV-derived genes were RefSeq genes, but those were not expressed in the OMM samples.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fviro-01-785678-g0001.tif"/>
</fig>
</sec>
<sec>
<title>Characterization of ERV-Derived Genes</title>
<p>Next, we examined the structures of these 43 genes overlapped with ERV-ORFs. In nine genes, ERV-ORFs were identical to full or partial coding sequences of host genes: <italic>ASPRV1, CAR1, CNBP, CTSD, GIN1, PEG10, RTL1, SUGP2</italic>, and <italic>TAF1</italic> (<xref ref-type="fig" rid="F2">Figure 2</xref>). In these genes, four genes&#x02014;<italic>ASPRV1, CAR1, PEG10</italic>, and <italic>RTL1</italic> &#x02014; were known to originate from ERVs or LTR-type retrotransposons and mammalian or Carnivora-specific genes. <italic>ASPRV1</italic> codes an aspartic protease conserved in mammals and has roles in skin maintenance (<xref ref-type="bibr" rid="B29">29</xref>). <italic>PEG10</italic> and <italic>RTL1</italic> are <italic>gag-pol</italic> genes derived from Ty3/Gypsy retrotransposon and were involved in placental development (<xref ref-type="bibr" rid="B30">30</xref>, <xref ref-type="bibr" rid="B31">31</xref>). <italic>CAR1</italic>, also known as <italic>syncytin-Car1</italic>, is a retroviral <italic>env</italic> gene conserved in Carnivora (<xref ref-type="bibr" rid="B32">32</xref>). Syncytin-Car1 protein is involved in the cell fusion of syncytiotrophoblast during placentation (<xref ref-type="bibr" rid="B32">32</xref>). We used these four definite retroviral genes for further analysis. The remaining five genes&#x02014;<italic>CNBP, CTSD, GIN1, SUGP2</italic>, and <italic>TAF1</italic>&#x02014;consist of several exons, and one exon identified as containing ERV-ORFs (<xref ref-type="fig" rid="F2">Figure 2A</xref>). Orthologs of these exons were found in at least chickens, mice, and humans and may be derived from ERVs before the divergence of birds and mammals. This possibility has been particularly suggested for <italic>GIN1</italic>, where its integrase domain shows a high similarity to the GIN element, an animal-specific DNA transposon that encodes a Gypsy/Ty3 retrotransposon-like integrase (<xref ref-type="bibr" rid="B33">33</xref>). On the other hand, to the best of our knowledge, no evidence has been reported to indicate that <italic>CNBP, CTSD, SUGP2</italic>, and <italic>TAF1</italic> were derived from transposons. It is also plausible that these genes independently acquired protein motifs similar to ERVs. Since it is beyond the focus of this study to make conclusions, we did not regard these five genes as ERV-derived genes in this study. Two splicing variants of <italic>CRADD</italic> were overlapped with two ERV-ORFs, although they were in the 5&#x02032; UTR. Therefore, <italic>CRADD</italic> was also removed for further analyses. Others were uncharacterized genes in the RefSeq database (i.e., genes whose names start with <italic>LOC</italic>), including non-coding genes or newly identified non-RefSeq genes. To identify sufficiently expressing genes, we collected genes that were expressed in the eight canine OMM samples with an average TPM &#x0003E; 1. Finally, we identified 11 ERV-derived genes, including the newly identified melanoma genes 1 to 4 (<italic>NMG-1</italic> to <italic>4</italic>), which were expressed in canine oral melanoma (<xref ref-type="table" rid="T2">Table 2</xref>). Since <italic>NMG-1</italic> to <italic>4</italic> overlapped with RepeatMasker track of an ERV group, CfERV1-int (<xref ref-type="fig" rid="F2">Figure 2B</xref>; <xref ref-type="supplementary-material" rid="SM6">Supplementary Figure 1</xref>), these genes are presumed to be derived from ERVs.</p>
<fig id="F2" position="float">
<label>Figure 2</label>
<caption><p>Gene structures of ERV-derived genes. <bold>(A)</bold> An example of an ERV-derived gene, <italic>CNBP</italic>, whose single exon overlapped with an ERV-ORF. The transcript track displays the coordinates generated by StringTie2. The ERV-ORF track displays the coordinates of ERV-ORFs obtained from gEVE version 1.1. RepeatMasker track displays the coordinates annotated by RepeatMasker downloaded from the UCSC genome browser. <bold>(B)</bold> Examples of other ERV-derived genes. Structures of the other ERV-derived genes were in <xref ref-type="supplementary-material" rid="SM6">Supplementary Figure 1</xref>.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fviro-01-785678-g0002.tif"/>
</fig>
</sec>
<sec>
<title>Identification of Upregulated ERV-Derived Genes in Canine OMM</title>
<p>Next, we identified the ERV-derived genes that showed higher expression levels in the OMM samples than those in healthy tissues. Although we did not conduct the transcriptome sequencing of control samples, we utilized publicly available RNA-seq data of eight canine OMM samples and three canine oral healthy samples, all of which were obtained from the SRA database (<xref ref-type="bibr" rid="B20">20</xref>) (<xref ref-type="supplementary-material" rid="SM1">Supplementary Table 1</xref>). Then, we found that four ERV-derived genes were significantly upregulated (<italic>PEG10, NMG-1, NMG-4</italic>, and <italic>LOC102155597</italic>), and two ERV-derived genes were down-regulated (<italic>ASPRV1</italic> and <italic>LOC10215559</italic>) in OMM (adjusted <italic>p</italic> &#x0003C; 0.05) (<xref ref-type="fig" rid="F3">Figures 3A,B</xref>, <xref ref-type="supplementary-material" rid="SM4">Supplementary Table 4</xref>). TPMs of these four upregulated genes varied among melanoma samples, but their expression levels were low in all healthy tissues (<xref ref-type="fig" rid="F3">Figure 3C</xref>). <italic>PEG10</italic> was reported as an important gene in several species of human cancers, such as hepatocellular carcinoma (<xref ref-type="bibr" rid="B34">34</xref>), breast cancer (<xref ref-type="bibr" rid="B35">35</xref>), lung cancer (<xref ref-type="bibr" rid="B36">36</xref>), and neuroendocrine prostate cancer (<xref ref-type="bibr" rid="B37">37</xref>). <italic>NMG-1</italic> and <italic>NMG-4</italic> are newly identified genes, and their expressions were experimentally verified by RT-PCR (<xref ref-type="fig" rid="F3">Figure 3D</xref>). <italic>NMG-1</italic> gene has a single transcript isoform that is composed of two exons, and its second exon was overlapped with four ERV-ORFs annotated by gEVE database (<xref ref-type="fig" rid="F2">Figure 2B</xref>). <italic>NMG-4</italic> gene has two transcripts, and both are composed of three exons. <italic>LOC102155597</italic> was overlapped with an Env-like ERV-ORF of 447 amino acid length (<xref ref-type="fig" rid="F2">Figure 2B</xref>). This <italic>env</italic> gene was previously designated as <italic>Canis-env2</italic> (<xref ref-type="bibr" rid="B32">32</xref>). We found that <italic>Canis-env2</italic> homologs located between <italic>BTN2A1</italic> and <italic>BTN1A1</italic> among six Carnivora species available in UCSC genome browser, and they were presumed to be orthologs (<xref ref-type="fig" rid="F4">Figure 4A</xref>). We found that the coding sequences of <italic>Canis-env2</italic> orthologs were under purifying selection, suggesting that the proteins are functionally important (<xref ref-type="fig" rid="F4">Figure 4B</xref>). This Canis-Env2 protein retains the signal peptide, the furin cleavage site, and the immunosuppressive domain, but not the transmembrane (TM) domain (<xref ref-type="fig" rid="F4">Figure 4C</xref>). Together, we successfully identified newly identified or uncharacterized retroviral coding genes expressed in canine OMM.</p>
<fig id="F3" position="float">
<label>Figure 3</label>
<caption><p>Differentially expressed ERV-derived genes. <bold>(A)</bold> Volcano plot representing fold changes and adjusted <italic>p</italic>-values (padj) between OMM and healthy oral tissues obtained from same sites in different individuals. Each dot represents one gene. Green dots indicate ERV-derived genes, and gray dots indicate the other genes. Names of significantly changed genes (padj &#x0003C; 0.05) are also represented. <bold>(B)</bold> MA plot representing fold changes and expression levels (baseMean). <bold>(C)</bold> TPM values of individual samples. Bars represent the means. OMM, oral malignant melanoma; HT, healthy tissue. <bold>(D)</bold> Agarose gels showing the RT-PCR products of <italic>NMG-1, NMG-4</italic>, and <italic>GAPDH</italic> that were amplified from OMM cell lines from four dogs with the primers shown in the left panel. Negative controls without the reverse transcriptase (RT) were included to confirm the absence of DNA contamination.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fviro-01-785678-g0003.tif"/>
</fig>
<fig id="F4" position="float">
<label>Figure 4</label>
<caption><p>Evolutionally conservation of an Env protein coded in <italic>LOC111094052</italic>. <bold>(A)</bold> Synteny block of <italic>LOC111094052</italic> in canFam3. <bold>(B)</bold> Purifying selection on the Env protein, Canis-Env2, coded in <italic>LOC111094052</italic>. Pairwise <italic>dN</italic>/<italic>dS</italic> values and amino acid <italic>p</italic>-distances of Canis-Env2 orthologs from six Carnivora species were represented in the double-entry table. Statistical significance of selection was estimated by the codon-based test of neutrality using Nei-Gojobori method [27]. &#x0002A;<italic>p</italic> &#x0003C; 0.01. <bold>(C)</bold> Amino acid sequence alignment of Canis-env2 orthologs. Colored amino acids represent characteristic domains. Signal peptide was detected using SignalP (version 5.0) (<ext-link ext-link-type="uri" xlink:href="https://services.healthtech.dtu.dk/service.php?SignalP-5.0">https://services.healthtech.dtu.dk/service.php?SignalP-5.0</ext-link>). Furin cleavage site has the RXXR motif. Immunosuppressive domain was identified by comparison to the CKS-17 peptide (NH<sub>2</sub>-LQNRIRGLDLLFLKEGGL-COOH) from the immunosuppressive domain conserved in retroviral Env proteins (<xref ref-type="bibr" rid="B38">38</xref>).</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fviro-01-785678-g0004.tif"/>
</fig>
</sec>
</sec>
<sec sec-type="discussion" id="s4">
<title>Discussion</title>
<p>In this study, we identified and characterized ERV-derived genes that are expressed in canine OMM samples (<xref ref-type="fig" rid="F1">Figures 1</xref>, <xref ref-type="fig" rid="F2">2</xref>). Among them, four ERV-derived genes are upregulated in melanoma compared to healthy tissues (<xref ref-type="fig" rid="F3">Figure 3</xref>). Though ERV-derived viral particles have been found in melanoma in humans and mice (<xref ref-type="bibr" rid="B3">3</xref>, <xref ref-type="bibr" rid="B7">7</xref>), we could not find such ERV-derived genes that could potentially produce viral particles. Since this study is based on the canine reference genome (canFam3), we could not detect newly generated genes in OMM genomes. Therefore, the relationship between polymorphisms and ERVs in the genome of canine OMM remains to be investigated. Even with these limitations, evolutionarily conserved as well as expressed ERV-derived genes were newly identified in canine OMM in this study (<xref ref-type="fig" rid="F4">Figure 4</xref>).</p>
<p><italic>PEG10</italic> is upregulated in several human cancers (<xref ref-type="bibr" rid="B39">39</xref>). Comprehensive expression analysis revealed that PEG10 is upregulated, especially in hepatocellular carcinoma and breast carcinoma (<xref ref-type="bibr" rid="B39">39</xref>). In hepatocellular carcinoma, PEG10 is involved in the TGF-&#x003B2;1-triggered epithelial-mesenchymal transmission, progressing metastasis (<xref ref-type="bibr" rid="B34">34</xref>). PEG10 interacts with SIAH1 and suppresses apoptosis of hepatocellular carcinoma (<xref ref-type="bibr" rid="B40">40</xref>). Though a correlation between <italic>PEG10</italic> and human melanoma has not been reported yet, considering the upregulation of <italic>PEG10</italic> in canine OMM, this gene may be involved in tumor development in various mammalian species.</p>
<p><italic>NMG-1</italic> and <italic>NMG-4</italic> are two ERV-derived genes that were newly identified in this study. Both retained fragmented ORFs and overlapped with CfERV1-int, a canine-specific ERV family. Therefore, these two genes are relatively new ERVs and may be under being disrupted in the canine genome by mutation. Since their expressions were suppressed to very low levels in healthy samples, they may become a valuable marker for OMM. Future studies on the correlation of the expression levels with malignancy are needed.</p>
<p><italic>LOC111094052</italic> is an Env-coding gene, conveniently named <italic>Canis-env2</italic> in the previous study (<xref ref-type="bibr" rid="B32">32</xref>). <italic>Canis-env2</italic> orthologs were identified in all mammals belonging to the four major lineages of the order Carnivora (<xref ref-type="fig" rid="F4">Figure 4A</xref>). Pairwise dN/dS values among orthologs were &#x0003C;1 (<xref ref-type="fig" rid="F4">Figure 4B</xref>), and their amino acid sequences were conserved (<xref ref-type="fig" rid="F4">Figure 4C</xref>), suggesting the functional importance of the protein. Therefore, <italic>Canis-env2</italic> has been under co-option as a host gene in the Carnivora. While the function of Canis-Env2 protein is still unknown, the structure of Canis-Env2 is very similar to a primate-specific Env protein, HEMO, which lost the TM domain by protease cleavage (<xref ref-type="bibr" rid="B41">41</xref>). In addition, <italic>env-panMars</italic>, an <italic>env</italic> gene conserved in marsupials, also lost the TM domain due to a stop codon before the TM domain. HEMO, Env-panMars, and Canis-Env2 retain immunosuppressive domains and may be involved in cancer immunity. Tumors expressing Env can avoid immune rejection when transplanted into mice (<xref ref-type="bibr" rid="B42">42</xref>). MCA205 tumor cells expressing ERV-FRD1 Env (Syncytin-2) and ERV3 Env suppress the immune rejection in mice depending on the immunosuppressive domains. Syncytin-2 and ERV3 are expressed in the placenta, and their immunosuppressive activities are thought to be conserved for fetal-maternal immunosuppression (<xref ref-type="bibr" rid="B43">43</xref>). Thus, aberrant expression of Canis-Env2 may have a role in suppressing immune systems against OMM.</p>
<p>Our current study has some limitations: the small number of samples as well as the lack of well-designed control groups. These are partially due to the inevitable circumstances that our sample collection was dependent on the hospital surgeries for domesticated dogs. Furthermore, the expression of the transcripts and proteins identified in our RNA-seq analysis were not immunohistologically validated. However, our analysis clearly indicated that four ERV-derived genes (<italic>PEG10, LOC111094052</italic>, and two fragmented-ORF genes) was expressed in canine OMM. These results indicate that even in dogs with relatively low ERV copy numbers, ERV-derived genes similar to those of humans and mice are expressed.</p>
</sec>
<sec sec-type="data-availability" id="s5">
<title>Data Availability Statement</title>
<p>The datasets presented in this study can be found in online repositories. The names of the repository/repositories and accession number(s) can be found in the article/<xref ref-type="sec" rid="s10">Supplementary Material</xref>.</p>
</sec>
<sec id="s6">
<title>Ethics Statement</title>
<p>The animal study was reviewed and approved by the Institutional Animal Experiment Ethics Committee of Yamaguchi University. Written informed consent was obtained from the owners for the participation of their animals in this study.</p>
</sec>
<sec id="s7">
<title>Author Contributions</title>
<p>KK and TMiy designed the study. AS, MY, and TMiz performed experiments. KK performed the computational analyses, with supervision by SN. KK, SN, TMiz, and TMiy prepared the manuscript. All authors reviewed the manuscript.</p>
</sec>
<sec sec-type="funding-information" id="s8">
<title>Funding</title>
<p>This work was supported by JSPS KAKENHI (Grant Numbers 20J22607 to KK, 19K22365 to SN, TMiz, and TMiy, 20K06775 to SN and TMiy, and 20H03150 to SN and TMiy).</p>
</sec>
<sec sec-type="COI-statement" id="conf1">
<title>Conflict of Interest</title>
<p>MY was employed by the company Anicom Specialty Medical Institute Inc. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec sec-type="disclaimer" id="s9">
<title>Publisher&#x00027;s Note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec> 
</body>
<back>
<sec sec-type="supplementary-material" id="s10">
<title>Supplementary Material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fviro.2021.785678/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fviro.2021.785678/full#supplementary-material</ext-link></p>
<supplementary-material xlink:href="Table_1.XLSX" id="SM1" mimetype="application/vnd.openxmlformats-officedocument.spreadsheetml.sheet" xmlns:xlink="http://www.w3.org/1999/xlink"/>
<supplementary-material xlink:href="Table_2.XLSX" id="SM2" mimetype="application/vnd.openxmlformats-officedocument.spreadsheetml.sheet" xmlns:xlink="http://www.w3.org/1999/xlink"/>
<supplementary-material xlink:href="Table_3.XLSX" id="SM3" mimetype="application/vnd.openxmlformats-officedocument.spreadsheetml.sheet" xmlns:xlink="http://www.w3.org/1999/xlink"/>
<supplementary-material xlink:href="Table_4.XLSX" id="SM4" mimetype="application/vnd.openxmlformats-officedocument.spreadsheetml.sheet" xmlns:xlink="http://www.w3.org/1999/xlink"/>
<supplementary-material xlink:href="Data_Sheet_1.ZIP" id="SM5" mimetype="application/zip" xmlns:xlink="http://www.w3.org/1999/xlink"/>
<supplementary-material xlink:href="Data_Sheet_2.docx" id="SM6" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<label>1.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Johnson</surname> <given-names>WE</given-names></name></person-group>. <article-title>Origins and evolutionary consequences of ancient endogenous retroviruses</article-title>. <source>Nat. Rev. Microbiol</source>. (<year>2019</year>) <volume>17</volume>:<fpage>355</fpage>&#x02013;<lpage>70</lpage>. <pub-id pub-id-type="doi">10.1038/s41579-019-0189-2</pub-id><pub-id pub-id-type="pmid">30962577</pub-id></citation></ref>
<ref id="B2">
<label>2.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Singh</surname> <given-names>S</given-names></name> <name><surname>Kaye</surname> <given-names>S</given-names></name> <name><surname>Gore</surname> <given-names>ME</given-names></name> <name><surname>McClure</surname> <given-names>MO</given-names></name> <name><surname>Bunker</surname> <given-names>CB</given-names></name></person-group>. <article-title>The role of human endogenous retroviruses in melanoma</article-title>. <source>Br J Dermatol.</source> (<year>2009</year>) <volume>161</volume>:<fpage>1225</fpage>&#x02013;<lpage>31</lpage>. <pub-id pub-id-type="doi">10.1111/j.1365-2133.2009.09415.x</pub-id><pub-id pub-id-type="pmid">19785608</pub-id></citation></ref>
<ref id="B3">
<label>3.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Muster</surname> <given-names>T</given-names></name> <name><surname>Waltenberger</surname> <given-names>A</given-names></name> <name><surname>Grassauer</surname> <given-names>A</given-names></name> <name><surname>Hirschl</surname> <given-names>S</given-names></name> <name><surname>Caucig</surname> <given-names>P</given-names></name> <name><surname>Romirer</surname> <given-names>I</given-names></name> <etal/></person-group>. <article-title>An endogenous retrovirus derived from human melanoma cells</article-title>. <source>Cancer Res.</source> (<year>2003</year>) <volume>63</volume>:<fpage>8735</fpage>&#x02013;<lpage>41</lpage>.<pub-id pub-id-type="pmid">14695188</pub-id></citation></ref>
<ref id="B4">
<label>4.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>B&#x000FC;scher</surname> <given-names>K</given-names></name> <name><surname>Trefzer</surname> <given-names>U</given-names></name> <name><surname>Hofmann</surname> <given-names>M</given-names></name> <name><surname>Sterry</surname> <given-names>W</given-names></name> <name><surname>Kurth</surname> <given-names>R</given-names></name> <name><surname>Denner</surname> <given-names>J</given-names></name></person-group>. <article-title>Expression of human endogenous retrovirus K in melanomas and melanoma cell lines</article-title>. <source>Cancer Res.</source> (<year>2005</year>) <volume>65</volume>:<fpage>4172</fpage>&#x02013;<lpage>80</lpage>. <pub-id pub-id-type="doi">10.1158/0008-5472.CAN-04-2983</pub-id><pub-id pub-id-type="pmid">16718269</pub-id></citation></ref>
<ref id="B5">
<label>5.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname> <given-names>SH</given-names></name> <name><surname>Kang</surname> <given-names>YJ</given-names></name> <name><surname>Jo</surname> <given-names>JO</given-names></name> <name><surname>Ock</surname> <given-names>MS</given-names></name> <name><surname>Baek</surname> <given-names>KW</given-names></name> <name><surname>Eo</surname> <given-names>J</given-names></name> <etal/></person-group>. <article-title>Elevation of human ERV3-1 env protein expression in colorectal cancer</article-title>. <source>J Clin Pathol.</source> (<year>2014</year>) <volume>67</volume>:<fpage>840</fpage>&#x02013;<lpage>4</lpage>. <pub-id pub-id-type="doi">10.1136/jclinpath-2013-202089</pub-id><pub-id pub-id-type="pmid">25016529</pub-id></citation></ref>
<ref id="B6">
<label>6.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nakagawa</surname> <given-names>S</given-names></name> <name><surname>Kawashima</surname> <given-names>M</given-names></name> <name><surname>Miyatake</surname> <given-names>Y</given-names></name> <name><surname>Kudo</surname> <given-names>K</given-names></name> <name><surname>Kotaki</surname> <given-names>R</given-names></name> <name><surname>Ando</surname> <given-names>K</given-names></name> <etal/></person-group>. <article-title>Expression of ERV3-1 in leukocytes of acute myelogenous leukemia patients</article-title>. <source>Gene.</source> (<year>2021</year>) <volume>773</volume>:<fpage>145363</fpage>. <pub-id pub-id-type="doi">10.1016/j.gene.2020.145363</pub-id><pub-id pub-id-type="pmid">33338509</pub-id></citation></ref>
<ref id="B7">
<label>7.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Li</surname> <given-names>MF</given-names></name> <name><surname>Muller</surname> <given-names>J</given-names></name> <name><surname>Xu</surname> <given-names>F</given-names></name> <name><surname>Hearing</surname> <given-names>VJ</given-names></name> <name><surname>Gorelik</surname> <given-names>E</given-names></name></person-group>. <article-title>Inhibition of melanoma-associated antigen expression and ecotropic retrovirus production in B16BL6 melanoma cells transfected with major histocompatibility complex class I genes</article-title>. <source>Cancer Res.</source> (<year>1996</year>) <volume>56</volume>:<fpage>4464</fpage>&#x02013;<lpage>74</lpage>.<pub-id pub-id-type="pmid">8813142</pub-id></citation></ref>
<ref id="B8">
<label>8.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pothlichet</surname> <given-names>J</given-names></name> <name><surname>Mangeney</surname> <given-names>M</given-names></name> <name><surname>Heidmann</surname> <given-names>T</given-names></name></person-group>. <article-title>Mobility and integration sites of a murine C57BL/6 melanoma endogenous retrovirus involved in tumor progression in vivo</article-title>. <source>Int J Cancer.</source> (<year>2006</year>) <volume>119</volume>:<fpage>1869</fpage>&#x02013;<lpage>77</lpage>. <pub-id pub-id-type="doi">10.1002/ijc.22066</pub-id><pub-id pub-id-type="pmid">16708391</pub-id></citation></ref>
<ref id="B9">
<label>9.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mangeney</surname> <given-names>M</given-names></name> <name><surname>Pothlichet</surname> <given-names>J</given-names></name> <name><surname>Renard</surname> <given-names>M</given-names></name> <name><surname>Ducos</surname> <given-names>B</given-names></name> <name><surname>Heidmann</surname> <given-names>T</given-names></name></person-group>. <article-title>Endogenous retrovirus expression is required for murine melanoma tumor growth <italic>in vivo</italic></article-title>. <source>Cancer Res</source>. (<year>2005</year>) <volume>65</volume>:<fpage>2588</fpage>&#x02013;<lpage>91</lpage>. <pub-id pub-id-type="doi">10.1158/0008-5472.CAN-04-4231</pub-id><pub-id pub-id-type="pmid">15805254</pub-id></citation></ref>
<ref id="B10">
<label>10.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lander</surname> <given-names>ES</given-names></name> <name><surname>Linton</surname> <given-names>LM</given-names></name> <name><surname>Birren</surname> <given-names>B</given-names></name> <name><surname>Nusbaum</surname> <given-names>C</given-names></name> <name><surname>Zody</surname> <given-names>MC</given-names></name> <name><surname>Baldwin</surname> <given-names>J</given-names></name> <etal/></person-group>. <article-title>Initial sequencing and analysis of the human genome</article-title>. <source>Nature.</source> (<year>2001</year>) <volume>409</volume>:<fpage>860</fpage>&#x02013;<lpage>921</lpage>. <pub-id pub-id-type="doi">10.1038/35057062</pub-id><pub-id pub-id-type="pmid">11237011</pub-id></citation></ref>
<ref id="B11">
<label>11.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Waterston</surname> <given-names>RH</given-names></name> <name><surname>Lindblad-Toh</surname> <given-names>K</given-names></name> <name><surname>Birney</surname> <given-names>E</given-names></name> <name><surname>Rogers</surname> <given-names>J</given-names></name> <name><surname>Abril</surname> <given-names>JF</given-names></name> <etal/></person-group>. <article-title>Initial sequencing and comparative analysis of the mouse genome</article-title>. <source>Nature.</source> (<year>2002</year>) <volume>420</volume>:<fpage>520</fpage>&#x02013;<lpage>62</lpage>. <pub-id pub-id-type="doi">10.1038/nature01262</pub-id><pub-id pub-id-type="pmid">12466850</pub-id></citation></ref>
<ref id="B12">
<label>12.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Platt</surname> <given-names>RN</given-names></name> <name><surname>Vandewege</surname> <given-names>MW</given-names></name> <name><surname>Ray</surname> <given-names>DA</given-names></name></person-group>. <article-title>Mammalian transposable elements and their impacts on genome evolution</article-title>. <source>Chromosom Res.</source> (<year>2018</year>) <volume>26</volume>:<fpage>25</fpage>&#x02013;<lpage>43</lpage>. <pub-id pub-id-type="doi">10.1007/s10577-017-9570-z</pub-id><pub-id pub-id-type="pmid">29392473</pub-id></citation></ref>
<ref id="B13">
<label>13.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname> <given-names>C</given-names></name> <name><surname>Wallerman</surname> <given-names>O</given-names></name> <name><surname>Arendt</surname> <given-names>ML</given-names></name> <name><surname>Sundstr&#x000F6;m</surname> <given-names>E</given-names></name> <name><surname>Karlsson</surname> <given-names>&#x000C5;</given-names></name> <name><surname>Nordin</surname> <given-names>J</given-names></name> <etal/></person-group>. <article-title>A novel canine reference genome resolves genomic architecture and uncovers transcript complexity</article-title>. <source>Commun Biol.</source> (<year>2021</year>) <volume>4</volume>:<fpage>1</fpage>&#x02013;<lpage>11</lpage>. <pub-id pub-id-type="doi">10.1038/s42003-021-01698-x</pub-id><pub-id pub-id-type="pmid">33568770</pub-id></citation></ref>
<ref id="B14">
<label>14.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nakagawa</surname> <given-names>S</given-names></name> <name><surname>Takahashi</surname> <given-names>MU</given-names></name></person-group>. <article-title>gEVE: a genome-based endogenous viral element database provides comprehensive viral protein-coding sequences in mammalian genomes</article-title>. <source>Database.</source> (<year>2016</year>) <volume>2016</volume>:<fpage>1</fpage>&#x02013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1093/database/baw087</pub-id><pub-id pub-id-type="pmid">27242033</pub-id></citation></ref>
<ref id="B15">
<label>15.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Prouteau</surname> <given-names>A</given-names></name> <name><surname>Andr&#x000E9;</surname> <given-names>C</given-names></name></person-group>. <article-title>Canine melanomas as models for human melanomas: clinical, histological, and genetic comparison</article-title>. <source>Genes.</source> (<year>2019</year>) <fpage>10</fpage>. <pub-id pub-id-type="doi">10.3390/genes10070501</pub-id><pub-id pub-id-type="pmid">31262050</pub-id></citation></ref>
<ref id="B16">
<label>16.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Khanna</surname> <given-names>C</given-names></name> <name><surname>Lindblad-Toh</surname> <given-names>K</given-names></name> <name><surname>Vail</surname> <given-names>D</given-names></name> <name><surname>London</surname> <given-names>C</given-names></name> <name><surname>Bergman</surname> <given-names>P</given-names></name> <name><surname>Barber</surname> <given-names>L</given-names></name> <etal/></person-group>. <article-title>The dog as a cancer model</article-title>. <source>Nat Biotechnol.</source> (<year>2006</year>) <volume>24</volume>:<fpage>1065</fpage>&#x02013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1038/nbt0906-1065b</pub-id><pub-id pub-id-type="pmid">16964204</pub-id></citation></ref>
<ref id="B17">
<label>17.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rowell</surname> <given-names>JL</given-names></name> <name><surname>McCarthy</surname> <given-names>DO</given-names></name> <name><surname>Alvarez</surname> <given-names>CE</given-names></name></person-group>. <article-title>Dog models of naturally occurring cancer</article-title>. <source>Trends Mol Med.</source> (<year>2011</year>) <volume>17</volume>:<fpage>380</fpage>&#x02013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1016/j.molmed.2011.02.004</pub-id><pub-id pub-id-type="pmid">21439907</pub-id></citation></ref>
<ref id="B18">
<label>18.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Maekawa</surname> <given-names>N</given-names></name> <name><surname>Konnai</surname> <given-names>S</given-names></name> <name><surname>Takagi</surname> <given-names>S</given-names></name> <name><surname>Kagawa</surname> <given-names>Y</given-names></name> <name><surname>Okagawa</surname> <given-names>T</given-names></name> <name><surname>Nishimori</surname> <given-names>A</given-names></name> <etal/></person-group>. <article-title>A canine chimeric monoclonal antibody targeting PD-L1 and its clinical efficacy in canine oral malignant melanoma or undifferentiated sarcoma</article-title>. <source>Sci Rep.</source> (<year>2017</year>) <volume>7</volume>:<fpage>1</fpage>&#x02013;<lpage>12</lpage>. <pub-id pub-id-type="doi">10.1038/s41598-017-09444-2</pub-id><pub-id pub-id-type="pmid">28827658</pub-id></citation></ref>
<ref id="B19">
<label>19.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Igase</surname> <given-names>M</given-names></name> <name><surname>Nemoto</surname> <given-names>Y</given-names></name> <name><surname>Itamoto</surname> <given-names>K</given-names></name> <name><surname>Tani</surname> <given-names>K</given-names></name> <name><surname>Nakaichi</surname> <given-names>M</given-names></name> <name><surname>Sakurai</surname> <given-names>M</given-names></name> <etal/></person-group>. <article-title>A pilot clinical study of the therapeutic antibody against canine PD-1 for advanced spontaneous cancers in dogs</article-title>. <source>Sci Rep.</source> (<year>2020</year>) <volume>10</volume>:<fpage>1</fpage>&#x02013;<lpage>16</lpage>. <pub-id pub-id-type="doi">10.1038/s41598-020-75533-4</pub-id><pub-id pub-id-type="pmid">33110170</pub-id></citation></ref>
<ref id="B20">
<label>20.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rahman</surname> <given-names>MM</given-names></name> <name><surname>Lai</surname> <given-names>Y</given-names></name> <name><surname>Husna</surname> <given-names>A</given-names></name> <name><surname>Chen</surname> <given-names>H</given-names></name> <name><surname>Tanaka</surname> <given-names>Y</given-names></name> <name><surname>Kawaguchi</surname> <given-names>H</given-names></name> <etal/></person-group>. <article-title>Transcriptome analysis of dog oral melanoma and its oncogenic analogy with human melanoma</article-title>. <source>Oncol Rep.</source> (<year>2019</year>) <volume>43</volume>:<fpage>16</fpage>&#x02013;<lpage>30</lpage>. <pub-id pub-id-type="doi">10.3892/or.2019.7391</pub-id><pub-id pub-id-type="pmid">31661138</pub-id></citation></ref>
<ref id="B21">
<label>21.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pertea</surname> <given-names>M</given-names></name> <name><surname>Kim</surname> <given-names>D</given-names></name> <name><surname>Pertea</surname> <given-names>GM</given-names></name> <name><surname>Leek</surname> <given-names>JT</given-names></name> <name><surname>Salzberg</surname> <given-names>SL</given-names></name></person-group>. <article-title>Transcript-level expression analysis of RNA-seq experiments with HISAT, StringTie and Ballgown</article-title>. <source>Nat Protoc.</source> (<year>2016</year>) <volume>11</volume>:<fpage>1650</fpage>&#x02013;<lpage>67</lpage>. <pub-id pub-id-type="doi">10.1038/nprot.2016.095</pub-id><pub-id pub-id-type="pmid">27560171</pub-id></citation></ref>
<ref id="B22">
<label>22.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Quinlan</surname> <given-names>AR</given-names></name> <name><surname>Hall</surname> <given-names>IM</given-names></name></person-group>. <article-title>BEDTools: a flexible suite of utilities for comparing genomic features</article-title>. <source>Bioinformatics.</source> (<year>2010</year>) <volume>26</volume>:<fpage>841</fpage>&#x02013;<lpage>2</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/btq033</pub-id><pub-id pub-id-type="pmid">20110278</pub-id></citation></ref>
<ref id="B23">
<label>23.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Robinson</surname> <given-names>JT</given-names></name> <name><surname>Thorvaldsd&#x000F3;ttir</surname> <given-names>H</given-names></name> <name><surname>Winckler</surname> <given-names>W</given-names></name> <name><surname>Guttman</surname> <given-names>M</given-names></name> <name><surname>Lander</surname> <given-names>ES</given-names></name> <name><surname>Getz</surname> <given-names>G</given-names></name> <etal/></person-group>. <article-title>Integrative genomics viewer</article-title>. <source>Nat Biotechnol.</source> (<year>2011</year>) <volume>29</volume>:<fpage>24</fpage>&#x02013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1038/nbt.1754</pub-id><pub-id pub-id-type="pmid">21221095</pub-id></citation></ref>
<ref id="B24">
<label>24.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Love</surname> <given-names>MI</given-names></name> <name><surname>Huber</surname> <given-names>W</given-names></name> <name><surname>Anders</surname> <given-names>S</given-names></name></person-group>. <article-title>Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2</article-title>. <source>Genome Biol.</source> (<year>2014</year>) <volume>15</volume>:<fpage>1</fpage>&#x02013;<lpage>21</lpage>. <pub-id pub-id-type="doi">10.1186/s13059-014-0550-8</pub-id><pub-id pub-id-type="pmid">25516281</pub-id></citation></ref>
<ref id="B25">
<label>25.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kent</surname> <given-names>WJ</given-names></name></person-group>. <article-title>BLAT&#x02014;the BLAST-like alignment tool</article-title>. <source>Genome Res.</source> (<year>2002</year>) <volume>12</volume>:<fpage>656</fpage>&#x02013;<lpage>64</lpage>. <pub-id pub-id-type="doi">10.1101/gr.229202</pub-id><pub-id pub-id-type="pmid">11932250</pub-id></citation></ref>
<ref id="B26">
<label>26.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kumar</surname> <given-names>S</given-names></name> <name><surname>Stecher</surname> <given-names>G</given-names></name> <name><surname>Li</surname> <given-names>M</given-names></name> <name><surname>Knyaz</surname> <given-names>C</given-names></name> <name><surname>Tamura</surname> <given-names>K</given-names></name></person-group>. <article-title>MEGA X: molecular evolutionary genetics analysis across computing platforms</article-title>. <source>Mol Biol Evol.</source> (<year>2018</year>) <volume>35</volume>:<fpage>1547</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1093/molbev/msy096</pub-id><pub-id pub-id-type="pmid">29722887</pub-id></citation></ref>
<ref id="B27">
<label>27.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Edgar</surname> <given-names>RC</given-names></name></person-group>. <article-title>MUSCLE: Multiple sequence alignment with high accuracy and high throughput</article-title>. <source>Nucleic Acids Res.</source> (<year>2004</year>) <volume>32</volume>:<fpage>1792</fpage>&#x02013;<lpage>97</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkh340</pub-id><pub-id pub-id-type="pmid">15034147</pub-id></citation></ref>
<ref id="B28">
<label>28.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nei</surname> <given-names>M</given-names></name> <name><surname>Gojobori</surname> <given-names>T</given-names></name></person-group>. <article-title>Simple methods for estimating the numbers of synonymous and nonsynonymous nucleotide substitutions</article-title>. <source>Mol Biol Evol.</source> (<year>1986</year>) <volume>3</volume>:<fpage>418</fpage>&#x02013;<lpage>26</lpage>. <pub-id pub-id-type="doi">10.1093/oxfordjournals.molbev.a040410</pub-id><pub-id pub-id-type="pmid">3444411</pub-id></citation></ref>
<ref id="B29">
<label>29.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Matsui</surname> <given-names>T</given-names></name> <name><surname>Miyamoto</surname> <given-names>K</given-names></name> <name><surname>Kubo</surname> <given-names>A</given-names></name> <name><surname>Kawasaki</surname> <given-names>H</given-names></name> <name><surname>Ebihara</surname> <given-names>T</given-names></name> <name><surname>Hata</surname> <given-names>K</given-names></name> <etal/></person-group>. <article-title>SASPase regulates stratum corneum hydration through profilaggrin-to-filaggrin processing</article-title>. <source>EMBO Mol Med.</source> (<year>2011</year>) <volume>3</volume>:<fpage>320</fpage>&#x02013;<lpage>33</lpage>. <pub-id pub-id-type="doi">10.1002/emmm.201100140</pub-id><pub-id pub-id-type="pmid">21542132</pub-id></citation></ref>
<ref id="B30">
<label>30.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ono</surname> <given-names>R</given-names></name> <name><surname>Nakamura</surname> <given-names>K</given-names></name> <name><surname>Inoue</surname> <given-names>K</given-names></name> <name><surname>Naruse</surname> <given-names>M</given-names></name> <name><surname>Usami</surname> <given-names>T</given-names></name> <name><surname>Wakisaka-Saito</surname> <given-names>N</given-names></name> <etal/></person-group>. <article-title>Deletion of Peg10, an imprinted gene acquired from a retrotransposon, causes early embryonic lethality</article-title>. <source>Nat Genet.</source> (<year>2006</year>) <volume>38</volume>:<fpage>101</fpage>&#x02013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1038/ng1699</pub-id><pub-id pub-id-type="pmid">16341224</pub-id></citation></ref>
<ref id="B31">
<label>31.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sekita</surname> <given-names>Y</given-names></name> <name><surname>Wagatsuma</surname> <given-names>H</given-names></name> <name><surname>Nakamura</surname> <given-names>K</given-names></name> <name><surname>Ono</surname> <given-names>R</given-names></name> <name><surname>Kagami</surname> <given-names>M</given-names></name> <name><surname>Wakisaka</surname> <given-names>N</given-names></name> <etal/></person-group>. <article-title>Role of retrotransposon-derived imprinted gene, Rtl1, in the feto-maternal interface of mouse placenta</article-title>. <source>Nat Genet.</source> (<year>2008</year>) <volume>40</volume>:<fpage>243</fpage>&#x02013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1038/ng.2007.51</pub-id><pub-id pub-id-type="pmid">18176565</pub-id></citation></ref>
<ref id="B32">
<label>32.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cornelis</surname> <given-names>G</given-names></name> <name><surname>Heidmann</surname> <given-names>O</given-names></name> <name><surname>Bernard-Stoecklin</surname> <given-names>S</given-names></name> <name><surname>Reynaud</surname> <given-names>K</given-names></name> <name><surname>Veron</surname> <given-names>G</given-names></name> <name><surname>Mulot</surname> <given-names>B</given-names></name> <etal/></person-group>. <article-title>Ancestral capture of syncytin-Car1, a fusogenic endogenous retroviral envelope gene involved in placentation and conserved in Carnivora</article-title>. <source>Proc Natl Acad Sci USA.</source> (<year>2012</year>) <volume>109</volume>:<fpage>E432</fpage>&#x02013;<lpage>41</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1115346109</pub-id><pub-id pub-id-type="pmid">22308384</pub-id></citation></ref>
<ref id="B33">
<label>33.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mar&#x000ED;n</surname> <given-names>I</given-names></name></person-group>. <article-title>GIN transposons: Genetic elements linking retrotransposons and genes</article-title>. <source>Mol Biol Evol.</source> (<year>2010</year>) <volume>27</volume>:<fpage>1903</fpage>&#x02013;<lpage>11</lpage>. <pub-id pub-id-type="doi">10.1093/molbev/msq072</pub-id><pub-id pub-id-type="pmid">20228153</pub-id></citation></ref>
<ref id="B34">
<label>34.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname> <given-names>M</given-names></name> <name><surname>Sui</surname> <given-names>C</given-names></name> <name><surname>Dai</surname> <given-names>B</given-names></name> <name><surname>Shen</surname> <given-names>W</given-names></name> <name><surname>Lu</surname> <given-names>J</given-names></name> <name><surname>Yang</surname> <given-names>J</given-names></name></person-group>. <article-title>PEG10 is imperative for TGF-&#x003B2;1-induced epithelial-mesenchymal transition in hepatocellular carcinoma</article-title>. <source>Oncol Rep.</source> (<year>2017</year>) <volume>37</volume>:<fpage>510</fpage>&#x02013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.3892/or.2016.5282</pub-id><pub-id pub-id-type="pmid">28004118</pub-id></citation></ref>
<ref id="B35">
<label>35.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Li</surname> <given-names>X</given-names></name> <name><surname>Xiao</surname> <given-names>R</given-names></name> <name><surname>Tembo</surname> <given-names>K</given-names></name> <name><surname>Hao</surname> <given-names>L</given-names></name> <name><surname>Xiong</surname> <given-names>M</given-names></name> <name><surname>Pan</surname> <given-names>S</given-names></name> <etal/></person-group>. <article-title>PEG10 promotes human breast cancer cell proliferation, migration and invasion</article-title>. <source>Int J Oncol.</source> (<year>2016</year>) <volume>48</volume>:<fpage>1933</fpage>&#x02013;<lpage>42</lpage>. <pub-id pub-id-type="doi">10.3892/ijo.2016.3406</pub-id><pub-id pub-id-type="pmid">26934961</pub-id></citation></ref>
<ref id="B36">
<label>36.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Deng</surname> <given-names>X</given-names></name> <name><surname>Hu</surname> <given-names>Y</given-names></name> <name><surname>Ding</surname> <given-names>Q</given-names></name> <name><surname>Han</surname> <given-names>R</given-names></name> <name><surname>Guo</surname> <given-names>Q</given-names></name> <name><surname>Qin</surname> <given-names>J</given-names></name> <etal/></person-group>. <article-title>PEG10 plays a crucial role in human lung cancer proliferation, progression, prognosis and metastasis</article-title>. <source>Oncol Rep.</source> (<year>2014</year>) <volume>32</volume>:<fpage>2159</fpage>&#x02013;<lpage>67</lpage>. <pub-id pub-id-type="doi">10.3892/or.2014.3469</pub-id><pub-id pub-id-type="pmid">25199998</pub-id></citation></ref>
<ref id="B37">
<label>37.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Akamatsu</surname> <given-names>S</given-names></name> <name><surname>Wyatt</surname> <given-names>AW</given-names></name> <name><surname>Lin</surname> <given-names>D</given-names></name> <name><surname>Lysakowski</surname> <given-names>S</given-names></name> <name><surname>Zhang</surname> <given-names>F</given-names></name> <name><surname>Kim</surname> <given-names>S</given-names></name> <etal/></person-group>. <article-title>The placental gene PEG10 promotes progression of neuroendocrine prostate cancer</article-title>. <source>Cell Rep.</source> (<year>2015</year>) <volume>12</volume>:<fpage>922</fpage>&#x02013;<lpage>36</lpage>. <pub-id pub-id-type="doi">10.1016/j.celrep.2015.07.012</pub-id><pub-id pub-id-type="pmid">26235627</pub-id></citation></ref>
<ref id="B38">
<label>38.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cianciolo</surname> <given-names>GJ</given-names></name> <name><surname>Copeland</surname> <given-names>TD</given-names></name> <name><surname>Oroszlan</surname> <given-names>S</given-names></name> <name><surname>Snyderman</surname> <given-names>R</given-names></name></person-group>. <article-title>Inhibition of lymphocyte proliferation by a synthetic peptide homologous to retroviral envelope proteins</article-title>. <source>Science.</source> (<year>1985</year>) <volume>230</volume>:<fpage>453</fpage>&#x02013;<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1126/science.2996136</pub-id><pub-id pub-id-type="pmid">2996136</pub-id></citation></ref>
<ref id="B39">
<label>39.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Xie</surname> <given-names>T</given-names></name> <name><surname>Pan</surname> <given-names>S</given-names></name> <name><surname>Zheng</surname> <given-names>H</given-names></name> <name><surname>Luo</surname> <given-names>Z</given-names></name> <name><surname>Tembo</surname> <given-names>KM</given-names></name> <name><surname>Jamal</surname> <given-names>M</given-names></name> <etal/></person-group>. <article-title>PEG10 as an oncogene: expression regulatory mechanisms and role in tumor progression</article-title>. <source>Cancer Cell Int.</source> (<year>2018</year>) <fpage>1</fpage>&#x02013;<lpage>10</lpage>. <pub-id pub-id-type="doi">10.1186/s12935-018-0610-3</pub-id><pub-id pub-id-type="pmid">30123090</pub-id></citation></ref>
<ref id="B40">
<label>40.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Okabe</surname> <given-names>H</given-names></name> <name><surname>Satoh</surname> <given-names>S</given-names></name> <name><surname>Furukawa</surname> <given-names>Y</given-names></name> <name><surname>Kato</surname> <given-names>T</given-names></name> <name><surname>Hasegawa</surname> <given-names>S</given-names></name> <name><surname>Nakajima</surname> <given-names>Y</given-names></name> <etal/></person-group>. <article-title>Involvement of PEG10 in human hepatocellular carcinogenesis through interaction with SIAH1</article-title>. <source>Cancer Res.</source> (<year>2003</year>) <volume>63</volume>:<fpage>3043</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="pmid">12810624</pub-id></citation></ref>
<ref id="B41">
<label>41.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Heidmann</surname> <given-names>O</given-names></name> <name><surname>B&#x000E9;guin</surname> <given-names>A</given-names></name> <name><surname>Paternina</surname> <given-names>J</given-names></name> <name><surname>Berthier</surname> <given-names>R</given-names></name> <name><surname>Deloger</surname> <given-names>M</given-names></name> <name><surname>Bawa</surname> <given-names>O</given-names></name> <etal/></person-group>. <article-title>HEMO, an ancestral endogenous retroviral envelope protein shed in the blood of pregnant women and expressed in pluripotent stem cells and tumors</article-title>. <source>Proc Natl Acad Sci USA.</source> (<year>2017</year>) <volume>114</volume>:<fpage>E6642</fpage>&#x02013;<lpage>51</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1702204114</pub-id><pub-id pub-id-type="pmid">28739914</pub-id></citation></ref>
<ref id="B42">
<label>42.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mangeney</surname> <given-names>M</given-names></name> <name><surname>Heidmann</surname> <given-names>T</given-names></name></person-group>. <article-title>Tumor cells expressing a retroviral envelope escape immune rejection <italic>in vivo</italic></article-title>. <source>Proc Natl Acad Sci USA</source>. (<year>1998</year>) <volume>95</volume>:<fpage>14920</fpage>&#x02013;<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.95.25.14920</pub-id><pub-id pub-id-type="pmid">9843991</pub-id></citation></ref>
<ref id="B43">
<label>43.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mangeney</surname> <given-names>M</given-names></name> <name><surname>Renard</surname> <given-names>M</given-names></name> <name><surname>Schlecht-Louf</surname> <given-names>G</given-names></name> <name><surname>Bouallaga</surname> <given-names>I</given-names></name> <name><surname>Heidmann</surname> <given-names>O</given-names></name> <name><surname>Letzelter</surname> <given-names>C</given-names></name> <etal/></person-group>. <article-title>Placental syncytins: genetic disjunction between the fusogenic and immunosuppressive activity of retroviral envelope proteins</article-title>. <source>Proc Natl Acad Sci USA.</source> (<year>2007</year>) <volume>104</volume>:<fpage>20534</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0707873105</pub-id><pub-id pub-id-type="pmid">18077339</pub-id></citation></ref>
</ref-list> 
</back>
</article> 